Pharmaceutics for mucosal administration

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5859048
SERIAL NO

08860459

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In pharmaceutics for mucosal administration containing pharmacologically active peptides or proteins and tolmetin or salts thereof exhibited very excellent effect as mucosal absorption enhancers. Furthermore, when the pharmaceutics for mucosal administration are for rectal administration, the suppository in which at least either the active ingredient, peptide or protein, or the mucosal absorption enhancer is converted to a complex with a high molecular compound dissolving in water at pH 5 or higher and together uniformly dispersed in a fatty suppository base exhibited markedly improved rectal absorbability compared with that of conventional pharmaceutics for rectal administration and at the same time increased stability of the peptide or protein which is the active ingredient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEIKOKU HORMANE MFG CO LTD5-1 AKASAKA 2-CHOME MINATO-KU TOKYO 107

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Oohashi, Masami Inagi, JP 3 31
Sakata, Junichi Machida, JP 5 47
Sunamoto, Masaru Sagamihara, JP 1 27
Uchida, Noriaki Kawasaki, JP 6 162

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation